Transcript NORTHWEST DIABETES

ATTENDANCE FORM
6th NORTH WEST LIPID FORUM 11th June 2013, 09:30-1600.
YES, I am able to attend the meeting on Tuesday 11 th June 2013
To reserve your place, please complete the form and return at your earliest
convenience to Mark Woodcock
Email: [email protected]
Fax: Tel: 0161 276 8946
Post:0161 276 4684
CORRESPONDENCE DETAILS
Name: ……………………………………………………………………………………………………………………...
GP Surgery/Hospital: .…….………………………………………………………………………………………….
Role/Position:……………………………………………………………………………………………………………
Address: …………………………………………………………………………………………………………………..
………………………………………………………………………………………………………………………………..
………………………………………………………………………………………………………………………………..
Postcode: …………………………………………………………………………….......................................
Contact Number: ……………………………………………………………………...................................
Email Address: …………………………………………………………………………………………………………
Please state any dietary requirements: …………………………………………………………………….
Signature: ………………………………………………………………………………………………………………..
Date: …………………………………………………………………………………………………………………………
Invitation
th
6
NORTH WEST
LIPID FORUM
11th June 2013
Date: Tuesday 11th June2013
Venue: Hilton Manchester Airport Hotel,
Manchester Airport, Outwood Lane, Manchester,
M90 4WP
CPD accreditation
5 CPD applied for
Organised by Dr Handrean Soran
The organiser will not receive speaker honorarium or any other fee for chairing the sessions and
organising the meeting
This educational meeting has received funding from Sanofi to cover logistical costs (including catering,
venue hire and speaker honoraria). Sanofi have had no input into the selection of speakers or topics for
this meeting.
University of Manchester
The Centre for Endocrinology &
Diabetes
Agenda
0915-0945
Registration, Tea and Networking
0945-1000
Welcome
Session 1
Chair: Professor Paul Durrington
1000-1050
HDL-C raising therapies: an update and a critical assessment.
Professor Arnold von Eckardstein, Head of the Institute of Clinical
Chemistry, University Hospital Zurich, Switzerland.
1050-1140
HDL functionality and LDL quality.
Dr Handrean Soran. Consultant Physician and Endocrinologist,
Central Manchester Foundation Trust, UK.
1140-1210
Tea & Coffee, Networking
Session 2
Chair: Dr Handrean Soran
1210-1300
Familial Hypercholesterolemia, beyond diagnosis and treatment:
genetic cascade screening
Dr Joep Defesche, Academic Medical Center, Amsterdam,
Netherlands.
1300-1415
Lunch
Session 3
Chair: Dr Lance Sandle
1415-1505
The importance of considering LDL-C as well as CVD risk if
statins are to be most effective. Professor Paul Durrington,
University of Manchester, UK.
1505-1555
Cost of not achieving LDL-C targets and new therapeutic LDL-C
lowering options. Dr Dermot Neely, Director of the Laboratory
services and Lead Consultant for the Lipid and Metabolic
Outpatient Clinics, Royal Victoria Hospital, Newcastle, UK.
1550
Close